Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Das, Hiranmoy ^a   George, Jon C ^b   Joseph, Matthew ^a   Das, Manjusri ^a   Abdulhameed, Nasreen ^b   Blitz, Anna ^b   Khan, Mahmood ^a   Sakthivel, Ramasamy ^c   Mao, Hai Quan ^d   Hoit, Brian D ^b   Kuppusamy, Periannan ^a   Pompili, Vincent J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Arteriocyte Inc   (United States)

^d Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; MOLECULAR SCAFFOLD; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN; CD133 ANTIGEN; CD34 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; RAT; STEM CELL EXPANSION; STEM CELL MOBILIZATION; STRESS STRAIN RELATIONSHIP; TREADMILL EXERCISE; TREATMENT RESPONSE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENE THERAPY; GENETICS; HEART INFARCTION; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); NUDE RAT; STEM CELL TRANSPLANTATION;

ANIMALIA; RATTUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; CONNEXIN 43; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE THERAPY; GLYCOPROTEINS; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, NUDE; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70350238176     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007325     Document Type: Article

References (51)

1. Gluckman EG, Roch VV, Chastang C (1997) Use of Cord Blood Cells for Banking and Transplant. Oncologist 2: 340-343.
2. Tse W, Bunting KD, Laughlin MJ (2008) New insights into cord blood stem cell transplantation. Curr Opin Hematol 15: 279-284.
3. Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451: 937-942.
4. Daley GQ, Scadden DT (2008) Prospects for stem cell-based therapy. Cell 132: 544-548.
5. Singh S, Arora R, Handa K, Khraisat A, Nagajothi N, et al. (2009) Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol 32: 176-180.
6. Reffelmann T, Konemann S, Kloner RA (2009) Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol 53: 305-308.
7. Brown JA, Boussiotis VA (2008) Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 127: 286-297.
8. Hackney JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, et al. (2002) A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci U S A 99: 13061-13066.
9. Stevens MM, George JH (2005) Exploring and engineering the cell surface interface. Science 310: 1135-1138.
10. Chua KN, Chai C, Lee PC, Tang YN, Ramakrishna S, et al. (2006) Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials 27: 6043-6051.
11. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
12. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, et al. (2000) Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 89: 189-195.
13. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, et al. (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247-256.
14. Wu KH, Mo XM, Zhou B, Lu SH, Yang SG, et al. (2009) Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem 107: 926-932.
15. Vale PR, Losordo DW, Milliken CE, Maysky M, Esakof DD, et al. (2000) Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102: 965-974.
16. Giordano FJ, Ping P, McKirnan MD, Nozaki S, DeMaria AN, et al. (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 2: 534-539.
17. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, et al. (1999) Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68: 830-836; discussion 836-837.
18. Hao X, Mansson-Broberg A, Blomberg P, Dellgren G, Siddiqui AJ, et al. (2004) Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 322: 292-296.
19. Kano MR, Morishita Y, Iwata C, Iwasaka S, Watabe T, et al. (2005) VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 118: 3759-3768.
20. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
21. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367.
22. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77.
23. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, et al. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 18: 3964-3972.
24. Asahara TMH, Takahashi T (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
25. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, et al. (2000) Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202.
26. Das H, Abdulhameed N, Joseph M, Sakthivel R, Mao HQ, et al. (2009) Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis. Cell Transplant 18: 305-318.
27. Laflamme MA, Zbinden S, Epstein SE, Murry CE (2007) Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2: 307-339.
28. Passier R, van Laake LW, Mummery CL (2008) Stem-cell-based therapy and lessons from the heart. Nature 453: 322-329.
29. Cao R, Bjorndahl MA, Religa P, Clasper S, Garvin S, et al. (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6: 333-345.
30. Kinnunen K, Korpisalo P, Rissanen TT, Heikura T, Viita H, et al. (2006) Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer. Acta Physiol (Oxf) 187: 447-457.
31. Lahteenvuo JE, Lahteenvuo MT, Kivela A, Rosenlew C, Falkevall A, et al. (2009) Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation 119: 845-856.
32. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, et al. (2005) Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112: I178-183.
33. Stamm C, del Nido PJ (2004) Protein kinase C and myocardial calcium handling during ischemia and reperfusion: lessons learned using Rhod-2 spectrofluorometry. Thorac Cardiovasc Surg 52: 127-134.
34. Erbs S, Linke A, Adams V, Lenk K, Thiele H, et al. (2005) Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97: 756-762.
35. Van Zant G, Liang Y (2003) The role of stem cells in aging. Exp Hematol 31: 659-672.
36. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, et al. (2006) Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140-2146.
37. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, et al. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622.
38. Hochman JS, Choo H (1987) Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75: 299-306.
39. White HD, Cross DB, Elliott JM, Norris RM, Yee TW (1994) Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 89: 61-67.
40. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, et al. (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637.
41. Uemura R, Xu M, Ahmad N, Ashraf M (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421.
42. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845-848.
43. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, et al. (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97: 1142-1151.
44. Leor J, Guetta E, Feinberg MS, Galski H, Bar I, et al. (2006) Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 24: 772-780.
45. Ibukiyama C (1996) Angiogenesis. Angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions. Jpn Heart J 37: 285-300.
46. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
47. Li M, Jendrossek V, Belka C (2007) The role of PDGF in radiation oncology. Radiat Oncol 2: 5.
48. Krausgrill B, Vantler M, Burst V, Raths M, Halbach M, et al. (2009) Influence of Cell Treatment with PDGF-BB and Reperfusion on Cardiac Persistence of Mononuclear and Mesenchymal Bone Marrow Cells after Transplantation into Acute Myocardial Infarction in Rats. Cell Transplant-in press.
49. Das H, Sugita M, Brenner MB (2004) Mechanisms of Vdelta1 gammadelta T cell activation by microbial components. J Immunol 172: 6578-6586.
50. Morgan EE, Faulx MD, McElfresh TA, Kung TA, Zawaneh MS, et al. (2004) Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 287: H2049-2053.
51. Feigenbaum H (1993) Echocardiography and coronary artery disease. Int J Card Imaging 9 Suppl 2: 55-67.